JPRN-UMIN000018788已完成2 期
Tissue-engineered cultured periosteum used with platelet-rich plasma and hydroxyapatite in treating human osseous defects: second phase of clinical trial. - Clinical effect of cultured periosteal sheet for treating chronic periodontitis.
iigata University0 个研究点目标入组 30 人开始时间: 2015年8月24日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Persons who do not accept written informed consent. 2. Persons not satisfied with a standard of biosafety level 1. 3. Persons who had severe systemic complications. 4. Un-completion of periodontal initial treatment. 5. Persons who were unable to accept for periodontal surgery. 6. Persons who had not one infrabony defect with probing depth: 6mm and more, clinical attachment level: 6mm and more. and osseous defect depth estimated to be 4mm and more radiographically. 7. Persons who had the allergy due to medication. 8. Persons who are judged to be unqualified for this study subjects by investigators.
研究者
相似试验
已完成
不适用
Cultivated epithelial sheet transplantation for corneal epithelial stem cell deficiencya) Steven's Johnson Syndrome b) Ocular cicatricial pemphigoid c) Chemical/ Thermal Burns of the Cornea d) Gelatinous Drop Like Dystrophy e) Salzmann Corneal Degeneration f) Congenital AniridiaJPRN-UMIN000002948Department of Ophthalmology, Keio University School of Medicine5
进行中（未招募）
1 期
The aim of this clinical study is to show the clinical efficacy and safety of SMDCs in patients suffering from FI, and to find the optimal cell count for the functional regeneration of the external anal sphincter.Fecal incontinence in female and male patients.MedDRA version: 17.0Level: LLTClassification code 10016296Term: Fecal incontinenceSystem Organ Class: 100000004856EUCTR2010-021463-32-BGInnovacell Biotechnologie AG252
进行中（未招募）
1 期
The aim of this clinical study is to show the clinical efficacy and safety of SMDCs in patients suffering from FI, and to find the optimal cell count for the functional regeneration of the external anal sphincter.Fecal incontinence in female and male patients.MedDRA version: 17.0Level: LLTClassification code 10016296Term: Fecal incontinenceSystem Organ Class: 100000004856EUCTR2010-021463-32-SIInnovacell Biotechnologie AG252
进行中（未招募）
1 期
A clinical trial comparing muscle cell treatment with placebo in fecal incontinence patientsMedDRA version: 20.0Level: LLTClassification code 10016296Term: Fecal incontinenceSystem Organ Class: 100000004856MedDRA version: 20.0Level: LLTClassification code 10055507Term: Fecal incontinence aggravatedSystem Organ Class: 100000004856Fecal incontinenceEUCTR2021-001376-42-ESInnovacell AG290
进行中（未招募）
1 期
A clinical trial comparing muscle cell treatment with placebo in fecal incontinence patientsFecal incontinenceEUCTR2021-001376-42-BGInnovacell AG290